MET MEDICAL EQUIPMENTS TECHNOLOGIES S.R.L

Their core work

MET is an Italian technology SME that develops ozone-based systems for crop protection — applying controlled ozone doses to eliminate fungal diseases, pests, and pathogens in vegetables and greenhouse crops without synthetic pesticides. Their background in medical equipment technology appears to have informed their approach to ozone generation and delivery, which they adapted for agricultural use. In practice, they design and build ozone sprayer equipment intended for use across the full crop cycle, from seed treatment through post-harvest handling. Their commercial proposition is a natural, chemical-free alternative to conventional crop disease control inputs.

What they specialise in

How they've shifted over time

In 2015, MET ran a small feasibility study (O3MET, €50k) to validate ozone therapy specifically for greenhouse crop defence — a narrow, proof-of-concept scope with no recorded technical keywords. By 2019, that concept had matured into a full product development project (OXIR, €1.19M) with a broadened scope covering crop pests, disease control, and purpose-built sprayer hardware, targeting the entire food supply chain from seed to retail. The shift is less a change in direction and more a deepening: they validated a niche idea, secured major EU backing, and built it into a commercial product.

MET is on a product commercialisation path — they have moved from feasibility to full development and are likely seeking market entry partnerships, distribution channels, or integration with precision agriculture platforms.

How they like to work

MET leads every project they enter — both H2020 participations are as coordinator, which is unusual for a micro-SME and signals strong internal technical ownership and willingness to carry project management responsibility. Their consortia are very small (2 unique partners, all Italian), suggesting they prefer tight, focused partnerships over broad multi-country networks. A future collaborator should expect MET to drive the technical agenda rather than play a support role.

MET has worked with only 2 partners across their H2020 history, all based in Italy, making their network extremely compact and domestically concentrated. This likely reflects the early-stage nature of their technology rather than a deliberate isolation strategy.

What sets them apart

MET occupies a rare intersection between industrial ozone equipment engineering and agricultural application — most agri-tech SMEs come from farming or chemistry backgrounds, not medical devices. This gives them a hardware-level understanding of ozone generation and dosing that pure agri-chem companies typically lack. For consortium builders targeting sustainable crop protection, residue-free food production, or organic-compatible disease management, MET brings a ready-built technology asset rather than a research concept.

Highlights from their portfolio

• OXIR
  The largest project in their portfolio at €1.19M, OXIR represents a full SME Phase 2 development award — the most competitive EU SME instrument grant — validating that MET's ozone crop protection concept met high commercial readiness standards.
• O3MET
  This Phase 1 feasibility project is notable as the origin point of MET's agri-ozone technology journey, demonstrating the classic EU SME instrument pathway from concept (€50k) to full product (€1.19M) within four years.